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Objective: To investigate the impact of clinical and demographic parameters on the 
duration of focal onset seizures with and without secondary generalization using 
precise duration measurements from intracranial electroencephalographic (iEEG) 
recordings.
Methods: Patients with unifocal epilepsy syndromes and iEEG recording were ret-
rospectively identified from the database of the local epilepsy center (2006-2016). 
Seizure duration was defined as time difference of iEEG seizure pattern onset and 
cessation. The seizure semiology was classified based on video recordings. Clinical 
and demographic data were extracted from patient reports.
Results: In total, 69 adults were included, and 654 focal onset seizures were analyzed. 
Focal to bilateral tonic-clonic seizures (FBTCSs; 98/654) were significantly longer 
than focal seizures (FSs) without generalization (FS-BTCs; 556/654, P < .001), and 
most FSs (545/654, 83.3%) terminated within 2 minutes. The duration of FSs was 
prolonged with increasing age of the patients (P = .003) and was significantly short-
ened (P < .001) by evolution into an FBTCS. FBTCSs with lateralizing semiologies 
like version (P = .015) and sign of four (P = .043) were associated with longer bi-
lateral tonic-clonic manifestations. Furthermore, FBTCSs with preceding aura, fron-
tal origin, or onset during sleep were by trend shorter. Age (P < .001) and disease 
duration (P = .028) were essential for prediction of FS-BTC duration, whereas the 
vigilance state (P = .085) was the main prediction factor for the duration of FBTCSs.
Significance: The identified modifiers of seizure duration are of great relevance for 
clinical risk evaluation, especially in the aging epilepsy patient suffering from tem-
poral lobe epilepsy with secondary generalized seizures.
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1 |  INTRODUCTION
Epileptic seizures are associated not only with social stigma-
tization, but also with a high injury risk. The risk for seizure 
complications is mainly influenced by the seizure severity, 
that is, clinical seizure manifestation and seizure duration.1–4 
Thus, prolonged, bilateral tonic-clonic seizures are associ-
ated with higher complication rates than shorter, focal sei-
zures (FSs) without generalization. It is for example known 
that the risk for musculoskeletal injuries, lung edema, ictal 
asystole, and sudden unexpected death in epilepsy rises with 
increasing seizure duration.2,5,6
Although the seizure duration seems to be a crucial risk 
factor, little is known about its drivers. It is common experi-
ence that most seizures stop without intervention mainly due 
to metabolic mechanisms like changes in ionic concentrations, 
increasing acidity, or neuromodulator release.7,8 Nevertheless, 
the seizure duration varies between epilepsy syndromes with, 
for example, longer focal impaired awareness seizures (FIASs) 
in mesial temporal than neocortical extratemporal epilepsy 
syndromes.9 Differences also exist between certain seizure 
semiologies like FIASs versus focal to bilateral tonic-clonic 
seizures (FBTCSs) or generalized tonic-clonic seizures.9–11 
Furthermore, seizures are longer in patients with history of 
status epilepticus and magnetic resonance imaging (MRI) le-
sion, and shorter in those with ictal dystonia, ictal hypoxia, and 
anticonvulsive treatment.11,12 This suggests that, in addition to 
common metabolic processes, the seizure duration is modulated 
by patient-specific parameters. However, systematic investiga-
tions of the interaction of clinical/demographic parameters and 
seizure duration are scarce.
All but three13–15 hitherto available studies on seizure du-
ration used surface electroencephalographic (EEG) record-
ings or video-based analyses,5,10,11,16 although intracranial 
EEG (iEEG) recording is superior in precise determination 
of seizure duration. The three studies addressing seizure du-
ration using iEEG electrodes examined either the duration of 
FIASs in temporal and extratemporal epilepsy syndromes13 
or characteristics of sleep-related hypermotor seizures,15 or 
focused on the impact of epilepsy syndromes and semiology 
only.14
To better understand the drivers of seizure duration, we 
aimed to systematically evaluate the impact of clinical and 
demographic factors like epilepsy syndrome, disease du-
ration, vigilance state at seizure onset, age, and sex on the 
duration of focal onset seizures with and without secondary 
generalization in patients with iEEG recordings.
2 |  MATERIALS AND METHODS
This study was approved by the institutional review board 
of Human Studies Research at the University of Munich. All 
participants gave written informed consent to the scientific 
use of their clinically acquired data.
2.1 | Participants
A retrospective database search was performed to identify 
all adult drug-resistant epilepsy patients who underwent 
an iEEG evaluation between January 2006 and June 2016 
(n = 128). The study was restricted to iEEG recordings as 
this allowed a more precise determination of the seizure du-
ration compared to analyses of surface EEG recordings. All 
patients had surface EEG recordings prior and in parallel to 
the iEEG recording.
To analyze the association of clinical and demographical 
parameters and seizure duration, study inclusion required at 
least one recorded clinical seizure with determinable seizure 
duration. Thus, patients with no recorded seizures, status 
epilepticus with undeterminable seizure pattern duration, or 
seizures with electrographic transition to periodic lateralized 
discharges or periodic bursting were excluded from statisti-
cal analyses (n  =  3). Furthermore, only the most clear-cut 
epilepsy cases, that is, patients with unifocal epilepsy syn-
dromes, were included in the study, to also assess the as-
sociation of seizure onset zone and seizure duration. The 
epilepsy syndrome classification resulted from an interdis-
ciplinary patient management conference and was based on 
the available EEG data, seizure semiology, electrical cortical 
stimulation, neuropsychological test results, and functional 
and structural imaging data. The latter were acquired on a 
3-T MRI scanner using a specific epilepsy protocol (high-res-
olution three-dimensional [3D] T1 and 3D fluid-attenuated 
inversion recovery [FLAIR] sequence, coronal FLAIR, T2, 
Key Points
• This is the first study to systematically analyze the 
association of the duration of focal seizures and 
clinical and demographic factors.
• A positive association was revealed for the dura-
tion of focal seizures and age of the patients.
• Male gender, preceding aura, frontal seizure onset, 
and seizure onset during sleep showed a large al-
though nonsignificant effect and might also influ-
ence the duration.
• Besides age, predicted seizure duration was pro-
longed with shortened disease duration and occur-
rence of version/sign of four.
• We suspect degenerating inhibition mechanisms 
in elderly patients as well as an essential role of 
the frontal lobe in seizure termination.
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and inversion recovery T1 sequence). Patients with multifo-
cality or unknown epileptic focus were excluded (n = 47), as 
were patients with unavailable MRI, relevant clinical, or EEG 
data (n  =  5), or missing consent for scientific use of their 
data (n = 4). The patient selection process is summarized in 
Figure 1.
2.2 | Clinical and demographic parameters
Clinical and demographic data with relevance for the study 
were extracted from the patient reports, including sex, age at 
disease onset, age at monitoring, epilepsy syndrome, disease 
etiology, antiepileptic drugs (AEDs), and type of EEG re-
cording (stereo-EEG [sEEG] vs subdural electrodes).
As generally accepted standard procedure, the AEDs 
were withdrawn during the presurgical evaluation in the 
epilepsy monitoring unit (EMU) to increase the likelihood 
of epileptic seizures. AED withdrawal was started upon ad-
mission to the EMU, that is, after implantation of the iEEG 
electrodes and postoperative exclusion of an intracranial 
hemorrhage. In patients with one or two AEDs, the medi-
cation was completely withdrawn within 1 day. In patients 
with at least three AEDs or history of status epilepticus, all 
but one AED were stopped on the first day and the remain-
ing AED was tapered during the following 1-3  days. If a 
patient experienced a generalized convulsive seizure or a se-
ries of three or more focal onset seizures, lorazepam 2.5 mg 
was administered sublingually. As reported separately, AED 
withdrawal did not influence the seizure duration in our 
study cohort.17
2.3 | Seizure duration determination
The seizure duration was determined based on the iEEG re-
cordings, that is, subdural and sEEG. Subdural electrodes 
were typically used in patients with a neocortical epilepsy 
focus, whereas sEEG electrodes were preferred for the EEG 
evaluation of more extensive or mesial or subcortical brain 
areas. The iEEG electrodes were individually placed ac-
cording to the suspected location of the seizure onset zone 
and associated evolution pathways. The EEG signal from 
the intracranial electrodes (AD-Tech Medical Instrument 
Corporation) was recorded using XLTEK Neuroworks soft-
ware and an XLTEK EMU128FS amplifier (Natus Medical 
Incorporated) with a sampling rate of 1024  Hz and 12- to 
16-bit A-D conversion. The seizure duration (in seconds) 
was determined as the time difference between EEG seizure 
pattern onset and cessation and validated by at least two ex-
perienced epileptologists who were blinded to the clinical 
and demographic parameters. Thereby, the seizure pattern 
end was defined as the cessation of ictal rhythmic activity 
in all EEG channels. In case of an asynchronous seizure pat-
tern cessation,18 the seizure end was always set at the time 
point of cessation of the latest detectable seizure pattern. For 
FBTCSs, the durations of the focal and the generalized phase 
were noted separately.
F I G U R E  1  The flow chart visualizes 
the patient selection process. In total, 128 
adult epilepsy patients were identified who 
underwent an evaluation with intracranial 
electroencephalography (EEG) during 
video-EEG monitoring (VEM) between 
January 2006 and June 2016. Exclusion 
of 59 patients due to missing consent to 
scientific use of their data, missing study-
relevant data, or undefinable seizure end 
yielded the final cohort of 69 patients. 
FLE, frontal lobe epilepsy; MRI, magnetic 
resonance imaging; PLED, periodic 
lateralized epileptiform discharge; POLE, 
parieto-occipital lobe epilepsy; TLE, 
temporal lobe epilepsy
   | 1379KAUFMANN et Al
2.4 | Semiological seizure evaluation
The video recordings of all seizures were evaluated with re-
gard to seizure semiology,19 including lateralizing signs like 
dystonia, sign of four, or a forced head and trunk rotation (ie, 
version). Especially ictal dystonia was reported to inhibit sec-
ondary generalization, presumably caused by an activation 
of the basal ganglia.12 Furthermore, the occurrence of aura 
symptoms and the time of day and vigilance state at seizure 
onset (sleep vs awake) were noted.
2.5 | Statistical analysis
Mean and standard deviation were calculated for quantita-
tive parameters. F tests were used to compare variances, and 
group differences were calculated using t tests. A negative 
binomial mixed model was fitted to analyze the association 
between the clinical and demographic parameters and the 
length of epileptic seizures, in a univariate as well as in a 
multivariate setting. Separate models were calculated for FSs 
without generalization (FS-BTCs), FBTCSs, and the focal 
and the generalized phase of FBTCSs. Sex, age, lobe, dis-
ease duration or age at disease onset, aura, and vigilance at 
seizure onset (sleep vs wakefulness) were thereby chosen as 
fixed effects. For FS-BTCs, dystonia was added as a fixed 
effect, whereas version and sign of four were considered as 
fixed effects for FBTCSs. In addition, a random intercept per 
patient was included in the model to account for the repeated 
measurements (multiple seizures per patient). The model 
selection was done via Akaike information criterion (AIC). 
This criterion is based on the goodness of fit (not P values) 
but penalizes model complexity. A P value < .05 was consid-
ered statistically significant.
3 |  RESULTS
3.1 | Demographics and clinical 
characteristics
This study included 69 adults (33 males, 36 females) with 
unifocal epilepsy. Most patients (47/69, 68.1%) had a struc-
tural etiology, and a similar number of patients were diag-
nosed with frontal (31/69, 44.9%) or temporal (30/69, 43.5%) 
lobe epilepsy (Table 1). The minority had a parieto-occipital 
epilepsy onset (8/69, 11.6%). The cohort was further char-
acterized by an equal distribution of left (33/69, 47.8%) and 
right (36/69, 52.2%) hemispheric epilepsy syndromes. Upon 
admission, mean disease duration was 20.4  ±  13.2  years, 
with a minimum of 2 and a maximum of 56 years. Age at 
monitoring was 36.51  ±  12.08  years. Most of the patients 
(40/69, 58.0%) were evaluated with sEEG, whereas subdural 
electrodes were used in 29 patients (29/69, 42.0%).
FLE TLE POLE Total
Total number 
of patients
31 30 8 69
Sex, male/
female





12/19 19/11 2/6 33/36




(n = 9); gyral 
malformation 
(n = 1); tumor 
(n = 7); 
porencephalic 








(n = 1); tumor 
(n = 5); vascular 
malformation  
(n = 1); focal 
atrophy (n = 1); 
sclerosis (n = 5); 
lesion/gliosis after 
TBI, resection, or 
encephalitis (n = 4)
Nonlesional (n = 2); 
focal cortical 
dysplasia (n = 2); 
diffuse atrophy  
(n = 1); gliosis 
after bleeding, 
bullet wound, or 
perinatal hypoxia 
(n = 3)
Abbreviations: FLE, frontal lobe epilepsy; MRI, magnetic resonance imaging; POLE, parieto-occipital lobe 
epilepsy; TBI, traumatic brain injury; TLE, temporal lobe epilepsy.
T A B L E  1  Patient characteristics
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3.2 | Seizure characteristics
In total, 654 FSs were recorded, of which 15.0% (98/654) 
showed an evolution to FBTCS. Their characteristics are 
summarized in Table 2. On average, the patients experienced 
9.5 seizures, with a maximum of 24 seizures/patient. The 556 
FS-BTCs had a mean duration of 76.7  seconds and an ex-
pected duration of 73.5 seconds (95% confidence interval [CI] 
= 60.5-89.1), with a wide variability ranging from 10  sec-
onds to a maximum of 690 seconds. In comparison, the 98 
FBTCSs lasted significantly longer (mean = 102.2 seconds, 
range = 15-429  seconds, expected value = 104.3  seconds, 
95% CI = 89.8-121.1, P < .001). Most FSs (545/654, 83.3%) 
self-terminated within 2 minutes, that is, 84.0% (467/556) of 
the FS-BTCs and 79.6% (78/98) of the FBTCSs. A prolonged 
duration of >5 minutes was detected in 21 of 654 (3.2%) sei-
zures of nine of 69 (13.0%) patients.
In addition, FSs were shortened by evolution into a 
FBTCS, meaning that the focal phases of FBTCSs (38.7 sec-
onds, 95% CI = 29.9-50.1) lasted significantly shorter than 
FS-BTCs (73.5  seconds, 95% CI = 60.5-89.1, P  <  .001; 
Figure 2).
3.3 | Association of seizure duration and 
demographic parameters
The duration of the FS-BTC was significantly associated 
with the age of the patient. Per year of life, the duration of 
FS-BTCs was prolonged by a factor of 1.022 (P = .003) in 
a univariate model. No significant association was found 
for the age of the patients and the duration of FBTCSs and 
their focal and generalized phases. Disease duration did not 
influence the seizure duration and thus did not account for 
the observed age dependency. Male gender did not alter the 
overall duration of FSs with or without generalization sig-
nificantly, but, compared to women, male patients showed 
FLE TLE POLE Total
Total number of 
seizures
343 225 86 654
Seizure onset, left/
right
148/195 142/83 7/79 297/357
Clinical/subclinical 
seizures
303/40 183/42 70/16 556/98
Preceding aura 68 (19.8%) 54 (24.0%) 38 (44.2%) 160 (24.5%)
Seizure onset during 
sleep




51 (14.9%) 31 (7.3%) 16 (18.6%) 98 (15.0%)
Version 31 (60.8%) 19 (61.3%) 8 (50.0%) 58 (59.2%)
Sign of four 13 (25.5%) 4 (12.9%) 2 (12.5%) 19 (19.4%)
Dystonia 0 (0%) 7 (3.1%) 1 (1.2%) 8 (1.2%)
Abbreviations: FBTCS, focal to bilateral tonic-clonic seizure; FLE, frontal lobe epilepsy; POLE, parieto-
occipital lobe epilepsy; TLE, temporal lobe epilepsy.
T A B L E  2  Seizure characteristics
F I G U R E  2  Duration of focal seizures in dependence of 
subsequent generalization. Focal onset seizures without evolution to 
bilateral tonic clonic seizures, that is, without secondary generalization 
(FS-BTC; n = 556) revealed a significantly longer duration than the 
focal parts of focal to bilateral tonic-clonic seizures (FBTCS; n = 98). 
In detail, focal seizures were significantly shortened by a subsequent 
generalization (*P < .001). The diagrams represent the respective 
mean (black lines), the expected value from the univariate model (red 
diamonds) and the observations, with the colored symbols representing 
individuals
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a tendency of shortened focal phases in FBTCSs (factor = 
0.783, P = .350).
3.4 | Association of seizure duration and 
epilepsy syndrome
In a univariate model, FS-BTC durations were shortest in 
patients with frontal lobe epilepsy (FLE; FS-BTCs: 55.9 sec-
onds, 95% CI = 33.5-93.3) and longest in patients with tem-
poral lobe epilepsy (TLE; FS-BTCs: 93.1 seconds, 95% CI 
= 71.1-122.0, P  =  .010; Figure  3). No significant differ-
ences were found for the duration of FBTCSs between FLE 
(94.2 seconds, 95% CI = 57.9-153.4), TLE (113.3 seconds, 
95% CI = 86.5-148.5, P = .590), and parieto-occipital lobe 
epilepsy (103.2  seconds, 95% CI = 66.4-160.4, P =  .398). 
The multivariate regression model, however, revealed no 
significant association between the epilepsy syndrome and 
the seizure duration.
3.5 | Association of seizure duration and 
seizure semiology
A preceding aura had no significant impact on the seizure 
duration in the univariate model, but it tended to shorten the 
focal phase of FBTCSs (factor = 1.621, P = .068). Strong lat-
eralizing semiologies like version and sign of four, however, 
were significantly associated with prolonged generalized 
phases in FBTCSs in the univariate (version factor = 1.349, 
P = .004; sign of four factor = 1.329, P = .012) as well as 
the selected multivariate (version factor = 1.290, P = .015; 
sign of four factor = 1.254, P = .043) models. Dystonia was 
observed in only eight seizures and did not reveal an associa-
tion with seizure duration.
The vigilance state at seizure onset, that is, sleep or wake-
fulness, had no significant impact on the duration of FSs in 
the univariate and multivariate models. However, the average 
duration of FBTCSs with seizure onset during sleep tended 
to be shorter than of those starting during wakefulness (factor 
= 0.825, P = .085). This nonsignificant effect was also ob-
served for the generalized phase of FBTCSs (factor = 0.828, 
P = .077).
3.6 | Seizure duration prediction
Model selection was done according to AIC, with a bet-
ter model having a lower AIC. For FS-BTCs, age (factor 
= 1.034/y, P <  .001) and disease duration (factor = 0.982, 
P = .028) remained in the selected model. The age depend-
ency of FS-BTCs is visualized in Figures 4 and 5 contrasts 
the predicted and observed FS-BTC durations.
In contrast, the vigilance state (sleep vs wakefulness; 
factor = 0.825, P = .085) was the core influencing factor 
in the FBTCS prediction model. Furthermore, the focal 
phase of FBTCSs was mainly influenced by the occur-
rence of an aura (factor = 1.663, P =  .068), whereas the 
duration of the generalized phase was significantly asso-
ciated with the appearance of lateralizing signs, that is, 
version (factor = 1.290, P = .015) or sign of four (factor 
= 1.254, P = .043).
The detailed results of the univariate, multivariate, and se-
lected models are available online as a supplement.
F I G U R E  3  Syndrome-specific seizure duration. A, Visualization of the duration of focal onset seizures without secondary generalization 
(FS-BTC; n = 556), subdivided into seizures with frontal (n = 292), temporal (n = 194), or parieto-occipital (n = 70) seizure onset. Here, patients 
with frontal lobe epilepsy revealed significantly shorter focal seizures than patients with temporal lobe epilepsy (*P < .0001). B, Illustration of 
the duration of focal to bilateral tonic-clonic seizures (FBTCS; n = 98). No significant difference was found between FBTCS of frontal (n = 51), 
temporal (n = 31), or parieto-occipital (n = 16) seizure onset. The diagrams represent the respective mean (black lines), the expected value from 
the univariate model (red diamonds), and the observations. For reasons of clarity, the data points of individual patients are highlighted in different 
colors and spread out along the x-axis. FLE, frontal lobe epilepsy; POLE, parieto-occipital lobe epilepsy; TLE, temporal lobe epilepsy
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4 |  DISCUSSION
This study is the first to systematically analyze the associa-
tion of the duration of focal onset seizures and demographic 
and clinical parameters, using iEEG to ensure precise seizure 
duration determination.
In accordance with previous publications,9,10,14,20 the 
seizure duration was significantly prolonged in the case 
of an evolution to FBTCS and the epileptic activity typ-
ically self-terminated within 2 minutes. Similar to previ-
ous reports,14,21 only 3.2% of seizures lasted >5 minutes. 
Thereby, the duration of FBTCSs appeared more stereo-
typic, that is, revealed a smaller variance, than the duration 
of FS-BTCs. Furthermore, the FS phase was significantly 
shortened in the case of an evolution to a bilateral ton-
ic-clonic seizure. Both suggest that early seizure evolu-
tion already differs between FBTCSs and FS-BTCs. This 
is supported by a recent description of unequal activation 
patterns in the regions surrounding the seizure onset zone 
during the preictal and early ictal phase of FBTCSs and 
FS-BTCs.22
4.1 | Clinical and demographic modifiers of 
seizure duration
Of note, the seizure duration was significantly prolonged by 
increasing age (FS-BTCs) and occurrence of version/sign of 
four (generalized phase of FBTCSs). Furthermore, the pre-
dicted FS-BTC duration was significantly impacted by the 
disease duration.
The longer seizure durations in aging epilepsy patients 
might indicate an age-dependent impairment of seizure 
termination. This could be explained by physiological, 
F I G U R E  4  Age-dependent and syndrome-specific duration of 
focal onset seizures. The graph reflects the age-dependent duration 
of a focal onset seizure in a patient with temporal lobe epilepsy 
(TLE; orange), frontal lobe epilepsy (FLE; blue), or parieto-occipital 
lobe epilepsy (POLE; green). The calculation was performed for a 
female patient with a disease duration of 5 years, assuming that the 
seizure occurred during the awake state, without preceding aura, and 
without ictal dystonia. The dashed lines represent the respective 95% 
confidence intervals
F I G U R E  5  Predicted seizure duration 
in model with age and disease duration. 
The level plot shows the observed (black 
dots) and the predicted duration of focal 
onset seizures dependent on age and disease 
duration. Seizure prediction was performed 
with the following covariates: female 
gender, disease duration of 5 years, seizure 
onset during awake state, no preceding aura, 
and no dystonia
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age-related neuronal degeneration, as it involves a gradual 
decrease of inhibitory networks with a reduced release of 
inhibitory neurotransmitters like γ-aminobutyric acid.23,24 
Thus, seizure termination might be less efficient in el-
derly patients, leading to the observed seizure prolonga-
tion. Accordingly, among adults, elderly patients have the 
highest incidence of epilepsy as well as the highest rate of 
status epilepticus.25–27 Further support of our hypothesis 
comes from a recent report that also described longer du-
rations of interictal epileptiform discharges in aging epi-
lepsy patients.28 No significant association, however, was 
found between the age of the patients and the duration of 
FBTCSs, which is most likely explained by the difference 
in group sizes, with a presumably underpowered analysis 
for FBTCSs (556 FS-BTCs vs 96 FBTCSs).
Longer FS-BTC durations were further observed in pa-
tients with shorter disease durations (selected/prediction 
model). The constellation of older age and short disease du-
ration is mainly given in older epilepsy patients with adult 
onset epilepsy syndromes and thus short disease histories. 
In this subgroup, the inhibitory networks are thought to be 
less definite than in patients with inherent epilepsy syn-
dromes,29,30 which might contribute to the differences in 
seizure duration.
The lateralizing signs "version" and "sign of four" 
typically occur at the beginning of secondary generaliza-
tions,31,32 and went along with significantly longer dura-
tions of FBTCSs. Both semiologies are associated with an 
epileptic activation of frontal brain regions, including the 
frontal eye field and the supplementary motor area.32–35 
Based on our results, we suggest that the frontal lobe might 
play an essential role in seizure inhibition: (1) as in earlier 
studies,11,20 FSs were shortest in FLE, indicating that they 
were more efficiently terminated by the surrounding fron-
tal brain regions than focal onset seizures with temporal 
or parieto-occipital origin; and (2) the extensive epileptic 
activation of the frontal lobe during version/sign of four 
might cause a functional inhibition of the frontal inhibitory 
mechanisms, leading to the prolonged seizure duration in 
FBTCSs.
In line with the first reports,11 seizures also tended to be 
shorter in male patients compared to female patients—al-
though we did not observe a significant association, most 
likely due to the insufficient cohort size. On a pathophys-
iological level, this observation might correlate with gen-
der differences in cerebral perfusion and a higher glucose 
uptake in females.36,37 Furthermore, female patients are 
characterized by a higher cerebral density of excitatory 
receptors and transmitters like serotonin and dopamine, 
which might facilitate seizure evolution and maintenance 
in women.38–40 Prospective gender studies including func-
tional measurements are needed to substantialize this 
hypothesis.
4.2 | Limitations
Although the 69 patients represent the typical drug-resistant 
patient population that can be found in adult EMUs, it is a 
highly selected cohort. Thus, our results cannot be trans-
ferred to a broader epilepsy population without limitations. 
Especially the elderly patients with late onset epilepsy syn-
dromes due to, for example, vascular lesions were under-
represented, as they usually become seizure-free under 
medication and thus do not undergo presurgical evaluations. 
Furthermore, our analyses were restricted to iEEG record-
ings only. However, presurgical iEEG recording is typically 
required in less clear-cut epilepsy cases with unclear seizure 
focus localization. Consequently, lateralizing semiologies 
like dystonia are less frequent in this patient cohort and were 
relatively underrepresented in our study compared to litera-
ture reports.32,35,41 Significant impact, however, was revealed 
for version and sign of four, which should be confirmed in 
a less selected epilepsy cohort. Moreover, iEEG electrodes 
cover only a limited brain region. Therefore, we cannot to-
tally rule out that an earlier EEG seizure onset or termination 
in more distant regions was missed. However, this is very 
unlikely, as we also paid attention to remote seizure patterns, 
correlated the EEG with the respective video recordings, and 
additionally used surface electrodes covering the rest of the 
brain. The analysis is further biased by an unequal number of 
seizures per patient, which was accounted for by including a 
random estimate in the statistical model. To record enough 
seizures during the video-EEG evaluation, it is common prac-
tice to withdraw the antiepileptic drugs after EEG electrode 
implantation. Although AED withdrawal increases the likeli-
hood of seizures, it was shown not to alter seizure duration.17 
Individual patients, however, received lorazepam as rescue 
medication after a series of focal onset seizures or bilateral 
tonic-clonic seizures. The respective seizures could not all be 
identified retrospectively and were thus not excluded from 
the analysis. Consequently, we cannot rule out a certain bias 
of the rescue medication on the seizure durations and thus our 
statistical analysis. However, the potential impact on our re-
sults is thought to be low, as the rescue medication was typi-
cally administered after the respective seizure end. Last but 
not least, we might have missed further essential modifiers of 
the seizure duration that we were not aware of and that were 
thus not included in the statistical model.
4.3 | Significance
Age, epilepsy syndrome, and lateralizing semiologies were 
identified as relevant modifiers of seizure duration in focal 
epilepsy patients. Although these parameters are noninflu-
enceable, they provide valuable insight into developmen-
tal network changes, seizure evolution, and termination 
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mechanisms, and are of great relevance for risk evaluation in 
adult epilepsy patients.
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